お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
567963

ゲノム編集の世界市場

Global Genome Editing Market - Segmented by Technology, Application, End-User, and Geography - Growth, Trends, and Forecast (2018 - 2023)

出版日: | 発行: Mordor Intelligence Pvt Ltd | ページ情報: 英文 110 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=104.68円
ゲノム編集の世界市場
出版日: 2018年03月01日
発行: Mordor Intelligence Pvt Ltd
ページ情報: 英文 110 Pages
納期: 2-3営業日
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

当レポートでは、ゲノム編集の世界市場について調査し、市場の概要、技術・応用領域・地域別の市場動向および市場予測、市場促進・阻害要因および市場機会・課題の分析、競合情勢、主要企業のプロファイルなどについて包括的にまとめています。

第1章 イントロダクション

  • 市場の定義
  • 調査手法

第2章 エグゼクティブサマリー

第3章 主な推論

第4章 市場概要

  • 市場概況
  • ファイブフォース分析

第5章 市場力学

  • 促進要因
  • 阻害要因
  • 市場機会
  • 市場課題

第6章 ゲノム編集の世界市場

  • 技術別
    • CRISPR
    • TALEN
    • ZFN
    • アンチセンス
    • その他
  • 応用領域別
    • 細胞株エンジニアリング
    • 動物遺伝子工学
    • 植物遺伝子工学
    • その他
  • 地域別
    • 北米
    • 欧州
    • アジア太平洋
    • 南米
    • 中東・アフリカ

第7章 競合環境

  • 合併・買収
  • 提携・協力・合意
  • 新製品の投入

第8章 企業プロファイル

  • Thermo Fisher Scientific, Inc.
  • Sangamo Biosciences, Inc.
  • GenScript USA, Inc.
  • Horizon Discovery Group plc
  • Merck & Co.
  • Origene Technologies, Inc.
  • Transposagen Biopharmaceuticals, Inc.
  • New England Biolabs, Inc.
  • Lonza Group Ltd.
  • Integrated DNA Technologies, Inc.
  • その他の企業

第9章 市場の将来展望

目次
Product Code: 55466

The global genome editing market is expected to register a CAGR of 14.5% during the forecast period, 2018 to 2023. North America dominates the market due to the factors, such as, increasing use of genetically modified crops and the development of gene therapy in the United States.

Technological Advancements in Genome Testing Market

Genetic modification has provided an approach for reverse genetics, analyzing gene function, and linking DNA sequence to phenotype. Traditional methods are now becoming obsolete, due to progress in the genome sequencing technologies, as a result of inefficient, time consuming, and labor intensive methods. Recent technologies, like ZFN, TALEN, and CRISPR/Cas9 nuclease, can initiate genome editing easily and precisely, with no limitations by the organism. These instruments have offered intriguing possibilities for conducting large-scale experiments. Thus, technological advancements are fuelling the growth of the genome testing market.

Additionally, rising incidences of chronic disease and increase in the demand for synthetic genes are driving the genome editing market.

Ethical Concerns Related to Genetic Research

Genome editing has indicated a good potential for the treatment of genetic disorders, infectious diseases, and cancer. Along with the advantages, there are growing concerns about the risks and ethical issues associated with genome editing, that affect the market. The major ethical issues, include the off-target mutation development, imbalance of the environment, and illegal usage of genome editing. The perspective of the general public toward gene editing is negative. Several scientists have advocated for the ban or prohibition of genome editing. This has created a lot of pressure on companies involved in genome editing, as they are unable to find suitable subjects to carry out clinical trials, resulting in the hindrance in the innovation. Thus, it is acting as a major restraint for the growth of genome testing market.

Additionally, high cost of genomic equipment is also acting as a restraint for the genome editing market.

North America to Dominate the Market

North America dominated the market in terms of revenue share, due to the higher adoption of advanced technique in the research institutes based in the United States. Additionally, genetic diseases, like cystic fibrosis, occur at a frequency of 1 in 2,500 birth in the United States.

Key Developments in the Market

  • February 2018: Kite and Sangamo Therapeutics collaborated for developing next-generation engineered cell therapies, for the treatment of cancer.
  • Major Players - THERMO FISHER SCIENTIFIC INC., SANGAMO BIOSCIENCES INC., GENSCRIPT USA INC., HORIZON DISCOVERY GROUP PLC, MERCK & CO., ORIGENE TECHNOLOGIES INC., TRANSPOSAGEN BIOPHARMACEUTICALS INC., NEW ENGLAND BIOLABS INC., LONZA GROUP LTD, and INTEGRATED DNA TECHNOLOGIES INC. amongst others.

Reasons to Purchase the Report

  • Market analysis for the genome editing market, with region-specific assessments and competition analysis on a global and regional scale.
  • Analyzing various perspectives of the industry with the help of Porter's five forces analysis.
  • The treatment type that is expected to dominate the market.
  • Regions that are expected to witness fastest growth during the forecast period.
  • Identify the latest developments, market shares, and strategies employed by the major market players.
  • 3 months analyst support, along with the Market Estimate sheet (in excel).

Customization of the Report

This report can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.

Table of Contents

1. Introduction

  • 1.1 Market Definition

2. Research Methodology

3. Executive Summary

4. Key Inferences

5. Market Overview

  • 5.1 Current Market Scenario
  • 5.2 Porter's Five Forces Analysis
    • 5.2.1 Bargaining Power of Suppliers
    • 5.2.2 Bargaining Power of Consumers
    • 5.2.3 Threat of New Entrants
    • 5.2.4 Threat of Substitute Product and Services
    • 5.2.5 Competitive Rivalry Within the Industry

6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)

  • 6.1 Market Drivers
    • 6.1.1 Rising Incidence of Chronic Diseases
    • 6.1.2 Rise in Production of Genetically Modified Crops
    • 6.1.3 Technological Advancements
    • 6.1.4 Increase in Demand for Synthetic Genes
    • 6.1.5 Increasing Government Funding and Growth in the Number of Genomics Projects
  • 6.2 Market Restraints
    • 6.2.1 High Cost of Genomic Equipment
    • 6.2.2 Ethical Concerns Related to Genetic Research
  • 6.3 Opportunities
  • 6.4 Key challenges

7. Market Segmentation

  • 7.1 By Technology
    • 7.1.1 CRISPR
    • 7.1.2 TALEN
    • 7.1.3 ZFN
    • 7.1.4 Meganucleases
    • 7.1.5 Others
  • 7.2 By Application
    • 7.2.1 Cell Line Engineering
    • 7.2.2 Animal Genetic Engineering
    • 7.2.3 Plant Genetic Engineering
    • 7.2.4 Others
  • 7.3 By End User
    • 7.3.1 Biotechnology and Pharmaceutical Companies
    • 7.3.2 Academic and Government Research Institutes
    • 7.3.3 Contract Research Organizations
  • 7.4 By Geography
    • 7.4.1 North America
      • 7.4.1.1 United States
      • 7.4.1.2 Canada
      • 7.4.1.3 Mexico
    • 7.4.2 Europe
      • 7.4.2.1 France
      • 7.4.2.2 Germany
      • 7.4.2.3 United Kingdom
      • 7.4.2.4 Italy
      • 7.4.2.5 Spain
      • 7.4.2.6 Rest of Europe
    • 7.4.3 Asia-Pacific
      • 7.4.3.1 China
      • 7.4.3.2 Japan
      • 7.4.3.3 India
      • 7.4.3.4 Australia & New Zealand
      • 7.4.3.5 South Korea
      • 7.4.3.6 Rest of Asia-Pacific
    • 7.4.4 Middle East & Africa
      • 7.4.4.1 GCC
      • 7.4.4.2 South Africa
      • 7.4.4.3 Rest of Middle East & Africa
    • 7.4.5 South America
      • 7.4.5.1 Brazil
      • 7.4.5.2 Argentina
      • 7.4.5.3 Rest of South America

8. Competitive Landscape

  • 8.1 Mergers and Acquisition Analysis
  • 8.2 Agreements, Collaborations, and Partnerships
  • 8.3 New Products Launches

9. Key Players

  • 9.1 GenScript USA Inc.
  • 9.2 Horizon Discovery Group plc
  • 9.3 Integrated DNA Technologies Inc.
  • 9.4 Lonza Group Ltd
  • 9.5 Merck & Co.
  • 9.6 New England Biolabs Inc.
  • 9.7 Origene Technologies Inc.
  • 9.8 Sangamo Biosciences Inc.
  • 9.9 Thermo Fisher Scientific Inc.
  • 9.10 Transposagen Biopharmaceuticals Inc.
  • 9.11 Others

10. Outlook of the Market

株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.